Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Accidental natalizumab administration to the third trimester of pregnancy in an adolescent patient with multiple sclerosis.
Administration of low dose-estrogen attenuates persistent inflammation, promotes angiogenesis and improves locomotor function following chronic spinal cord injury in rats.
No Regional Gray Matter Atrophy Differences between Pediatric- and Adult-Onset Relapsing-Remitting Multiple Sclerosis.
Cutting edge: Natalizumab blocks adhesion but not initial contact of human T cells to the blood-brain barrier in vivo in an animal model of multiple sclerosis.
In vitro assessment of the direct effect of laquinimod on basic functions of human neural stem cells and oligodendrocyte progenitor cells.
Role of statins in the treatment of multiple sclerosis.
Daphnetin Alleviates Experimental Autoimmune Encephalomyelitis via Regulating Dendritic Cell Activity.
Motor programme activating therapy influences adaptive brain functions in multiple sclerosis: clinical and MRI study.
Cyclophosphamide is effective in stabilizing rapidly deteriorating secondary progressive multiple sclerosis.
Elevated melatonin levels in natalizumab-treated female patients with relapsing-remitting multiple sclerosis: Relationship to oxidative stress.
The safety of exercise training in multiple sclerosis: A systematic review.
Exploring the human tear fluid: discovery of new biomarkers in multiple sclerosis.
Cognitive impairment as unusual first manifestation in late-onset relapsing-remitting multiple sclerosis.
No increase in cancer incidence detected after cyclophosphamide in a French cohort of patients with progressive multiple sclerosis.
T-cell vaccination in Crohn's disease: principles and presentation of the first two cases.
Safety and efficacy of fingolimod in treatment-naïve multiple sclerosis patients.
Patient perceptions of multiple sclerosis and its treatment.
Minocycline chelates Ca2+, binds to membranes, and depolarizes mitochondria by formation of Ca2+-dependent ion channels.
Chronic cerebrospinal venous insufficiency: Case-control neurosonography results.
Minocin
Multiple sclerosis: An old drug plays a new trick.
Laquinimod, a Quinoline-3-Carboxamide, Induces Type II Myeloid Cells That Modulate Central Nervous System Autoimmunity.
Prescriber utilization of dalfampridine extended release tablets in multiple sclerosis: a retrospective pharmacy and medical claims analysis.
Treatment of human spasticity with delta 9-tetrahydrocannabinol.
Low dose naltrexone therapy in multiple sclerosis.

Pages